Gain Therapeutics, Inc. GANX
0.94 USD -0.10 (-9.60%)
Regular-session close
0.94 0.00 -0.01%
After hours · Nov 16, 6:24 PM ET
0.9401 Day range 1.08
0.94 52-week range 4.34
- YTD
- -70.80%
- 1 year
- -66.78%
News
zacks.com Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know Gain Therapeutics (GANX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).benzinga.com Gain Therapeutics Q3 EPS $(0.07) Beats $(0.12) Estimate Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.12) by 41.67 percent. This is a 53.33 percent increase over losses of…
globenewswire.com Gain Therapeutics Reports Financial Results for Third Quarter 2026 and Provides Corporate Update BETHESDA, Md., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the…
